4.2 Article

Th17 and regulatory T cells: implications for AIDS pathogenesis

期刊

CURRENT OPINION IN HIV AND AIDS
卷 5, 期 2, 页码 151-157

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/COH.0b013e328335c0c1

关键词

HIV; indoleamine 2,3-dioxygenase; regulatory T cells; Th17 cells

资金

  1. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK083334, T32DK007762, K24DK060617] Funding Source: NIH RePORTER
  2. NIDDK NIH HHS [T32 DK007762, K08 DK083334, K08 DK083334-01A1, K24 DK060617] Funding Source: Medline

向作者/读者索取更多资源

Purpose of review The present review discusses recent reports showing that reciprocal changes in T helper interleukin-17-secreting CD4(+) Th17 cells and CD4(+)CD25(high)FoxP3(+) regulatory T cells (Tregs) may play a role in the progressive disease caused by the HIV and by simian immunodeficiency virus. Recent findings Studies in nonhuman primate models of lentiviral infection and in HIV-infected human individuals have shown that pathogenic infection is associated with loss of Th17 cells and an increase in the frequency of Tregs. Because interleukin-17 serves to maintain the integrity of the mucosal barrier, loss of Th17 cells may permit the increase in microbial translocation across the gastrointestinal mucosa that is observed in pathogenic lentiviral disease. It remains unclear, however, whether Th17 cells are preferentially infected or if, instead, their loss is induced by bystander effects of lentiviral infection, for example, the induction of indoleamine 2,3-dioxygenase. Summary Progressive lentiviral disease is associated with preferential depletion of Th17 cells and loss of Th17/Treg balance. Further analysis of such changes in the composition of subset CD4(+) T helper and Tregs may shed new light on the immunopathology of HIV disease and suggest new strategies for therapeutic and preventive interventions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据